V

Veru
D

VERU

0.57900
USD
-0.02
(-2.97%)
مغلق
حجم التداول
11,974
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
84,756,290
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGEN
    -0.11500
    (-3.34%)
    3.33000 USD
    C
    CTMX
    -0.03570
    (-4.38%)
    0.78000 USD
    E
    ESPR
    -0.03500
    (-1.88%)
    1.82500 USD
    L
    LPCN
    -0.15000
    (-4.27%)
    3.36000 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    المزيد
الأخبار
المقالات

العنوان: Veru

القطاع: Healthcare
الصناعة: Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.